News
15 July 2008Novo Nordisk files for regulatory approval of liraglutide in Japan
24 June 2008Novo Nordisk receives approval in the US for PrandiMet(TM)
16 June 2008Significant weight loss sustained in obese people treated with liraglutide for one year
Latest financial releaseStock quotes
ADA 2008 investor and analyst meeting
Webcast from the investor and analyst meeting on 8 June at 5 pm PT in San Francisco (corresponding to 9 June at 2 am CET). Novo Nordisk's executive management is represented by Chief Science Officer, Mads Krogsgaard Thomsen, Chief Operating Officer, Kåre Schultz and Chief Financial Officer, Jesper Brandgaard.
Click here to listen to the audio webcast
Click here to download the slides
Calender
| Date | Event | |
|---|---|---|
| 8 August 2008 - 15 August 2008 | Q2 2008 roadshow | |
| 3 September 2008 | Sal. Oppenheim's 3rd European Healthcare Investor Conference, Frankfurt | |
| 5 September 2008 - 6 September 2008 | Credit Suisse 8th Annual European Large Cap Pharma Conference, London | |
| 16 September 2008 - 18 September 2008 | Merrill Lynch Global healthcare conference, London | |
| 26 September 2008 | Capital Markets Day 2008, Copenhagen |